Brand-name tirzepatide (Zepbound and Mounjaro) is sold at a high monthly list price, so the fastest way to learn your own number is to call your insurer and your pharmacy, then compare it with the manufacturer’s self-pay options. What you pay with coverage depends on copay, coinsurance, and deductible. Eligible Medicare Part D members now have a predictable option through the Medicare GLP-1 Bridge.
TL;DR:
- Ask your insurer whether the prescription’s indication is covered, then confirm its formulary tier, deductible status, and copay or coinsurance before filling it.
- Get the exact strength, formulation, and quantity, then compare insured and pharmacy cash quotes with manufacturer direct purchase prices, including clinic fees and shipping.
- Eligible Medicare Part D beneficiaries may pay $50 monthly through the Medicare Bridge until December 31, 2027, if their drug and indication qualify.
- Since maintenance requires continued treatment and stopping is linked to weight regain, calculate long term costs and update estimates when your dose or plan changes.
Table of Contents
- What do published tirzepatide prices look like?
- What determines your monthly tirzepatide cost?
- Self-pay and manufacturer programs: what are your options?
- How do insurance, PBMs, and Medicare change what you pay?
- How do you estimate your own monthly out-of-pocket cost?
- What are practical ways to lower your monthly spending?
- What do trials say about how long treatment lasts?
- How long do people stay on tirzepatide, and what does that cost over time?
- How does tirzepatide cost compare with other GLP-1 medications we offer?
- Why does tirzepatide cost differ by location?
- What does our program cost beyond the medication?
- Our perspective: weigh the cost against the benefit
- How we can help you access GLP-1 treatment at a predictable price
- FAQ
- Sources
What do published tirzepatide prices look like?
Sticker price and real price are two different things with tirzepatide. The manufacturer publishes a list price for each pen strength, and that figure is what insurers and pharmacy benefit managers negotiate against. Cash and self-pay prices tend to land below list, and your insured price can land far above or far below either one.
We do not quote a specific list-price figure here, because we have no verified source in front of us for current pen pricing, and prices change often. The manufacturer pricing pages for Zepbound and Mounjaro are the place to confirm today’s numbers. Here is how to read what you find:
- Zepbound is the brand approved for chronic weight management. Its listed price is per monthly carton, and it is the version most people mean when they search for the cost of tirzepatide for weight loss.
- Mounjaro is the same active ingredient, labeled for type 2 diabetes. Its list price is commonly reported in a similar band, but coverage rules differ because the indication differs.
- Single-dose pens versus vials are priced differently. Vial-based self-pay programs from the manufacturer are typically positioned as the lower-cost cash route.
- Dose matters. Some self-pay programs price each strength separately, so a starting dose and a maintenance dose can carry different monthly costs.
Reading the numbers: the U.S. is known for list prices well above those in other countries, and rebate mechanics can separate list price from the net price a plan pays, as the FTC’s administrative complaint describes. That gap is why two patients on the same pen can pay very different amounts.
Cash-pay prices you will see advertised by telehealth clinics, retail pharmacies, and discount programs vary with dose, formulation, and what is bundled in. A pharmacy cash price covers the drug alone. A clinic price may fold in the provider visit, shipping, and coaching. Comparing them fairly means asking what each one includes, which we cover in the estimation checklist below. For a deeper look at the cash-pay side, see our GLP-1 cost without insurance guide and our breakdown of Zepbound cost.
What determines your monthly tirzepatide cost?
Several variables decide where you land, and you can check them before you ever step into a pharmacy.
- Dose and titration. Tirzepatide starts low and steps up over weeks. Higher maintenance doses usually cost more per month under pen-based pricing, and some programs price by strength. Our tirzepatide dosing schedule shows how the escalation unfolds, which helps you anticipate when your price may change.
- Indication. A prescription written for type 2 diabetes is treated differently from one written for chronic weight management. Many plans cover diabetes drugs but exclude weight-loss drugs, so the same molecule can be covered under one brand and denied under the other.
- Formulation. Pens, vials, and single-dose packaging carry different prices, and the choice often depends on what your prescriber writes and what your pharmacy stocks.
- Plan design. A flat copay is the most predictable. Coinsurance charges a percentage of the price, so a high list price raises your share. A deductible means you may pay close to full price until it is met.
- Pharmacy and formulary. Your plan’s pharmacy benefit manager decides whether tirzepatide is on the formulary, at what tier, and which pharmacies count as in-network. Access and price can both shift when that decision changes. For a quick map of which GLP-1 brands exist and how they are indicated, our FDA-approved GLP-1 medication list is a useful reference.
Pro Tip: Ask your prescriber which indication and formulation they are writing the prescription for before you price anything, because that single detail can move you from covered to denied.
Self-pay and manufacturer programs: what are your options?
If you are uninsured, underinsured, or your plan excludes weight-loss drugs, direct-pay routes are worth a close look. They come in different forms, and each prices differently.
- Manufacturer self-pay or vial programs. The manufacturer sells directly to patients through its own channel, typically with a price per strength and without insurance involved. Confirm the current price on the manufacturer’s page, because these programs change.
- Retail pharmacy cash price or discount card. This is the drug alone, at whatever your pharmacy charges a cash customer. It can differ noticeably from one pharmacy to the next, so calling around pays off.
- Cash-pay clinic or telehealth program. These usually bundle a provider assessment, the prescription, shipping, and follow-up support into one price. Our program, for example, includes free provider visits and unlimited coaching, and we ship without insurance or membership fees. A bundle can look pricier than a pharmacy cash price until you add the visit and support fees you would otherwise pay separately.
Clinic pricing models differ widely. A local partner clinic’s itemized peptide therapy cost breakdown is a good example of how a patient-facing, line-by-line price sheet looks, and it is the kind of transparency to ask any provider for.
One caution on compounded versions. Compounded tirzepatide is not the same as the FDA-approved brand, and its safety and quality depend on the source. Read our article on compounded tirzepatide safety and check current FDA guidance before choosing a cheaper unapproved route. This is general information, not legal or medical advice.
Affordability is a real concern, not a niche one. KFF polling found that about half of GLP-1 users say these drugs are difficult to afford, and that 27% of insured users said they paid the full cost themselves.
How do insurance, PBMs, and Medicare change what you pay?
Coverage design decides your share more than the drug does. Four terms matter:
- Copay: a fixed dollar amount per fill. Predictable, and unaffected by list price.
- Coinsurance: a percentage of the drug’s price. When the list price is high, your percentage share is high too.
- Deductible: the amount you pay before the plan starts sharing costs. In that phase you may pay close to the full negotiated price.
- Formulary tier: the plan’s ranking of a drug. Higher tiers carry higher copays or coinsurance, and some drugs sit off the formulary entirely or require prior authorization.
Why list price reaches your wallet. Pharmacy benefit managers negotiate rebates with manufacturers and decide formulary placement. The FTC has alleged that some middleman practices inflate list prices and shape formularies in ways that can push higher costs onto patients who pay coinsurance or sit in a deductible phase. The allegations in that case concern insulin, but the mechanism helps explain why a rebate that lowers the plan’s net cost does not always lower yours. If your share is a percentage of list price, rebates on the back end do nothing for you at the counter.
The Medicare GLP-1 Bridge. Medicare’s GLP-1 Bridge demonstration lets eligible beneficiaries get certain GLP-1 medications for $50 per month, and it runs through December 31, 2027. Per CMS documentation for Part D plans, participating manufacturers supply eligible drugs at a $245 net price per monthly supply, the beneficiary copay is $50, and Bridge coverage runs outside the standard Part D payment flow, so it does not count toward true out-of-pocket (TrOOP) costs. Two practical points follow:
- It is a time-limited demonstration, not a permanent change to Part D.
- Eligibility rules apply, so confirm that your specific drug and indication qualify before you count on the $50.
Pro Tip: Call your plan and ask three questions: is the drug on the formulary, what tier is it, and am I in the deductible phase right now? Those answers predict your next fill better than any price list.
For employer plans, ask your benefits team whether weight-management drugs are covered at all, since many employers exclude them and some offer exceptions.
How do you estimate your own monthly out-of-pocket cost?
Work through these steps in order. Each takes a few minutes and narrows your range.
- Get the script details. Ask your prescriber for the exact drug name, strength, formulation, and quantity. If available, get the National Drug Code, which lets a pharmacy or insurer price the exact product.
- Check your plan. Look up the drug’s formulary status and tier, then your copay or coinsurance rate, and where you stand on the deductible. Your insurer’s member portal or customer service line can confirm all three.
- Price-check at the pharmacy. Ask what your insured price would be and what the cash price is. Then compare both with the manufacturer’s self-pay program and any telehealth bundle you are considering.
- Add the extras. Include shipping, provider visit fees, telehealth or clinic charges, and refill timing. A lower drug price can be offset by separate visit costs, and a bundle can be cheaper than it looks if it covers those.
Pro Tip: Write each option down with the same four lines: drug price, visit fees, shipping, and support. Comparing totals, not headline prices, is how you avoid being surprised on the second month.
What are practical ways to lower your monthly spending?
A few moves tend to pay off fastest, and none requires special access.
- Check manufacturer programs. Look for coupons, patient-assistance offers, and self-pay vial options on the manufacturer’s site. Eligibility depends on insurance status, so read the terms.
- Compare pharmacies. Cash prices differ between pharmacies, and discount programs or mail-order can sometimes beat the local counter.
- Ask about dosing and formulation. Your prescriber may know of dosing strategies or formulations that fit your budget and your clinical plan. Never change a dose on your own.
- Appeal denials. If your plan denies coverage, ask your prescriber to support an appeal, and check whether your employer offers coverage exceptions.
- Time your fills. Know where you are in your deductible, since your cost can drop sharply once it is met.
Pro Tip: Keep a running note of every call: who you spoke to, the date, and the quoted price. It strengthens an appeal and keeps you from repeating work.
What do trials say about how long treatment lasts?
Cost matters more because tirzepatide for weight loss is generally not a short course. The SURMOUNT-4 randomized trial showed that continued treatment preserved weight reduction compared with switching to placebo, which points to ongoing treatment, and ongoing cost, for maintenance. Clinical experts reviewing the evidence, including a George Washington University public health summary, emphasize the same point: discontinuation is associated with significant weight regain.
Affordability is already a barrier. KFF polling found that about 1 in 8 adults report currently taking a GLP-1 drug and that about half of users say the drugs are difficult to afford.
Policy activity is also reshaping the picture. Federal scrutiny of pharmacy benefit managers and programs like the Medicare GLP-1 Bridge influence list prices and which options are available to you.
How long do people stay on tirzepatide, and what does that cost over time?
Plan for the long run rather than a single month. Because stopping tends to bring weight back, many patients and prescribers treat tirzepatide as ongoing therapy, with the dose stepping up and then holding at a maintenance level.
The cumulative cost is simple arithmetic you can do yourself. Take your confirmed monthly price, including any visit and support fees, and multiply it by the number of months you expect to be on treatment. Use your own quote for the calculation, since costs vary.
Three things can change the total over time. Your dose may rise, which can change your price under strength-based pricing. Your deductible resets each plan year, which can raise your cost in the early months of a year. And program rules can shift, since the Medicare Bridge, for instance, is time-limited through the end of 2027. Build a small buffer into your budget for these changes, and revisit your estimate each time you change dose or plan year.
How does tirzepatide cost compare with other GLP-1 medications we offer?
We offer several GLP-1 options, so you can compare within one program. Our listed pricing is straightforward: our GLP-1 injections start from $159 one-off, our GLP-1 tablets start from $249 one-off, and our semaglutide program starts from $159 per month. Our Zepbound injection, Wegovy injection, and Wegovy pill are available; current pricing details are on our site.
A few points help you compare fairly. Semaglutide and tirzepatide are different molecules, and which one fits you is a clinical decision made with a provider. Tablets and injections suit different preferences, and their prices differ. And a one-off price is not the same as a monthly price, so line up the billing period before you compare. Our FDA-approved GLP-1 list explains how the brands differ, and a provider assessment decides what is appropriate for you.
Why does tirzepatide cost differ by location?
Even within the U.S., two people can see different quotes. Several factors drive the differences:
- Your insurer and plan. Formularies, tiers, and cost-sharing vary by plan and by state regulation, so a neighbor’s price is not your price.
- Pharmacy. Cash prices differ between chains, independents, and mail-order, and some stock only certain strengths.
- Clinic or provider fees. Visit and support charges vary by practice and region.
- Program availability. Some manufacturer and state-level assistance options depend on where you live and what coverage you hold.
We cannot give you a state-by-state price table, because that would require data we do not have. What we can tell you is to get quotes from at least two pharmacies and one direct-pay program in your own area. Local differences are real, but they are usually smaller than the gap between insured and uninsured pricing.
What does our program cost beyond the medication?
The medication is only one line on the bill, so we spell out the rest. Our program is built around bundled services: a telehealth provider assessment, a prescription when it is appropriate, free shipping, personalized plans, and unlimited ongoing coaching and support. Provider visits are free, and we charge no membership fees and do not require insurance.
That bundling matters for the math. If you price a medication at a pharmacy, you still pay separately for the prescriber visit, any follow-ups, and whatever support you want. With our structure, those pieces sit inside the quote. Our published starting prices are from $159 one-off for GLP-1 injections, from $249 one-off for GLP-1 tablets, and from $159 per month for the semaglutide program. For Zepbound, Wegovy, and other listed products, current pricing details are on our site. Ask for the full quote before you commit, and compare it against the totals you wrote down in your own estimate.
Our perspective: weigh the cost against the benefit
Tirzepatide works, and the trial evidence says it works best when you stay on it, so the honest question is not only what it costs this month but what a sustained plan costs and whether you can keep it going. Price your plan across a full year before you start, confirm coverage, and talk with a clinician about whether you qualify. We also offer a telehealth route with bundled services, if that fits how you want to proceed.
— Bryan
How we can help you access GLP-1 treatment at a predictable price
If you would rather not stitch together a pharmacy, a prescriber, and a support program, we built our service to bring those pieces together. Legacy Meds offers a telehealth assessment, prescription access to GLP-1 medications, and ongoing support, with no insurance or membership fees. Here is what you get:
- A telehealth provider assessment with free visits
- Prescription access to GLP-1 medications when appropriate
- Free shipping and a personalized plan
- Unlimited coaching and support
Our GLP-1 injections start from $159 one-off, and our GLP-1 tablets start from $249 one-off. Check our GLP-1 offerings or request a personalized price quote today, and we will walk you through the next step.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
FAQ
How much does tirzepatide cost without insurance?
It depends on the strength, the formulation, and where you buy it, so there is no single number. Compare the manufacturer’s self-pay program, your pharmacy’s cash price, and any telehealth bundle, and total the visit and shipping fees for each. We cover this in more depth in our cash-pay guide.
Who should not take tirzepatide?
The FDA prescribing information lists contraindications, including a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. It also warns people to tell a provider about symptoms such as a neck mass or trouble swallowing. A clinician decides whether it is right for you.
What happens if you stop taking GLP-1 drugs?
Weight regain is common after stopping. In the SURMOUNT-4 trial, continuing treatment preserved weight loss compared with switching to placebo. Talk with your prescriber before stopping or changing your plan.
Does Medicare cover tirzepatide?
Eligible Part D beneficiaries may get certain GLP-1 medications for a $50 monthly copay through the Medicare GLP-1 Bridge, a demonstration available through December 31, 2027. Confirm that your drug and indication qualify under the program rules.